TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23098160

Group type: EXPERIMENTAL
Intervention: Bedtime regimen
Number of subjects: 2899

Group type: COMPARATOR
Intervention: Upon-awakening regimen
Number of subjects: 2899

Group type: COMPARATOR
Intervention: BID regimen
Number of subjects: 2899
Study: 21574730

Group type: EXPERIMENTAL
Intervention: Increased positive partner support
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Decreased negative partner support
Number of subjects: 81
Study: 18279623

Group type: EXPERIMENTAL
Intervention: Ropivacaine and morphine through thoracic epidural preoperatively (group PE)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Ropivacaine and morphine through thoracic epidural postoperatively (group E)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Intravenous infusion of fentanyl postoperatively (group IV)
Number of subjects: 105
Study: 15970448

Group type: EXPERIMENTAL
Intervention: Salmeterol (42 microg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 14521679

Group type: EXPERIMENTAL
Intervention: Action research methodology
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 11112957

Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone
Number of subjects: 6
Study: 8955966

Group type: EXPERIMENTAL
Intervention: Epidural clonidine (300 micrograms)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intramuscular clonidine (300 micrograms)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 60
Study: 1573044

Group type: EXPERIMENTAL
Intervention: lorazepam (2 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: buspirone (20 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: buspirone (10 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: secobarbital (100 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15
Study: 3889230

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with methotrexate and leucovorin followed by regional therapy and additional methotrexate courses every three months for one year.
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with a combination of Adriamycin and cisplatin every three weeks for four cycles after the first 35 patients.
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Prognostic categories based on expected outcome for each specific tumor site and stage.
Number of subjects: 82
Study: 29220534

Group type: EXPERIMENTAL
Intervention: Real acupuncture group (AcG)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Sham acupuncture group (ShG)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Simulated acupuncture group (SiG)
Number of subjects: 75
Study: 27194493

Group type: EXPERIMENTAL
Intervention: TXA IV and IA group (1 g IV preoperatively and 3 g IA postoperatively)
Number of subjects: 60

Group type: COMPARATOR
Intervention: TXA IV and placebo group (1 g IV preoperatively and 100 mL saline IA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TXA IV and IA group
Number of subjects: 60

Group type: COMPARATOR
Intervention: TXA IV and placebo group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 24915800

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 μg.kg(‐1) loading dose followed by 0.5 μg.kg(‐1).h(‐1) infusion)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Saline 0.9% (bolus and infusion of equivalent volume)
Number of subjects: 100
Study: 23059920

Group type: EXPERIMENTAL
Intervention: 5% NaF varnish
Number of subjects: 379

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 379
Study: 20660548

Group type: EXPERIMENTAL
Intervention: Noninvasive continuous positive airway pressure (nCPAP) via helmet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Noninvasive continuous positive airway pressure (nCPAP) via facial mask
Number of subjects: 20
Study: 18999175

Group type: EXPERIMENTAL
Intervention: New analytical method for EHR data
Number of subjects: 0
Study: 16500052

Group type: COMPARATOR
Intervention: CEE 0.625mg/day and placebo
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: CEE 0.625mg/day and fenretinide 100mg/bid
Number of subjects: 226

Group type: COMPARATOR
Intervention: E2 50microg/day and placebo
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: E2 50microg/day and fenretinide
Number of subjects: 226
Study: 14651279

Group type: EXPERIMENTAL
Intervention: Dental-bonding agent (Solist) followed by resin composite (Ecusit)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dental adhesive (Prompt) and resin composite (Pertac II)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Traditional calcium hydroxide (Dycal) plus resin composite (Ecusit)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Light-curing calcium hydroxide (Ultrablend Plus) and amalgam (Dentsply)
Number of subjects: 24
Study: 11040229

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg once daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (normotensives and group A hypertensives)
Number of subjects: 30
Study: 8687150

Group type: EXPERIMENTAL
Intervention: Tamoxifen (Nolvadex) for at least 3 years
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus tamoxifen
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Chemotherapy alone
Number of subjects: 81

Group type: COMPARATOR
Intervention: Tamoxifen or chemotherapy plus tamoxifen
Number of subjects: 81

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 81
Study: 1534581

Group type: EXPERIMENTAL
Intervention: Isradipine 2.5 mg twice daily
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 6441224

Group type: EXPERIMENTAL
Intervention: Cefonicid 1.0 g
Number of subjects: 141

Group type: COMPARATOR
Intervention: Penicillin 4.8 X 10(6) units plus 1.0 g of probenecid
Number of subjects: 141
Study: 30616462

Group type: EXPERIMENTAL
Intervention: Gastric H. pylori treatment plus periodontal therapy
Number of subjects: 698

Group type: COMPARATOR
Intervention: Gastric H. pylori treatment alone
Number of subjects: 698
Study: 29489568

Group type: EXPERIMENTAL
Intervention: Early Physical Therapy (PT) for 3 weeks
Number of subjects: 119

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 119
Study: 27246405

Group type: EXPERIMENTAL
Intervention: Goal Management Training + Mindfulness Meditation (GMT+MM)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (no-intervention)
Number of subjects: 32
Study: 23975119

Group type: EXPERIMENTAL
Intervention: Behavioural intervention group with additional guidance for sun-protection
Number of subjects: 395

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 395
Study: 22311995

Group type: EXPERIMENTAL
Intervention: Child-targeted intervention (massage and humor therapy)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Child and parent intervention (massage and relaxation/imagery)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 171
Study: 20604800

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus (LGG, 10^10 colony forming units)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study: 17657948

Group type: EXPERIMENTAL
Intervention: Antihomotoxic therapy
Number of subjects: 40
Study: 16156884

Group type: EXPERIMENTAL
Intervention: Nevirapine
Number of subjects: 160

Group type: COMPARATOR
Intervention: Protease Inhibitor (PI)
Number of subjects: 160
Study: 11914565

Group type: EXPERIMENTAL
Intervention: 150 ml of crystalloid solution for preloading (Group A)
Number of subjects: 22

Group type: COMPARATOR
Intervention: 15 ml/kg of crystalloid solution for preloading (Group B)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 22
Study: 10023505

Group type: EXPERIMENTAL
Intervention: Fluoxetine (n = 10)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (n = 9)
Number of subjects: 19
Study: 7588161

Group type: EXPERIMENTAL
Intervention: Ribavirin (3 days)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Ribavirin
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 44
Study: 2260153

Group type: EXPERIMENTAL
Intervention: Nimodipine 120 mg orally
Number of subjects: 871

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 871
Study: 6105024

Group type: EXPERIMENTAL
Intervention: Standard breakfast
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral glucose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous glucose
Number of subjects: 0
Study: 31191790

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression along with conventional treatment
Number of subjects: 89

Group type: COMPARATOR
Intervention: Cold-pack treatment along with conventional treatment
Number of subjects: 89
Study: 29257757

Group type: EXPERIMENTAL
Intervention: Formulation containing buradae sandal safaid, safoofe maghze tukhme bakayin, safoofe khaste tamar hindi and safoofe shakkar safaid, 10 g B.D for 21 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combination of azithromycin, fluconazole and secnidazole, single dose
Number of subjects: 0
Study: 26549488

Group type: EXPERIMENTAL
Intervention: TASK II intervention (n=123)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Information, support, and referral group (n=131)
Number of subjects: 254
Study: 24293555

Group type: EXPERIMENTAL
Intervention: Spontaneous breathing trial (SBT) group
Number of subjects: 139

Group type: COMPARATOR
Intervention: No spontaneous breathing trial (no-SBT) group
Number of subjects: 139
Study: 22058347

Group type: EXPERIMENTAL
Intervention: 0.05% chlorhexidine diacetate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1% povidone-iodine
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.9% saline control
Number of subjects: 60
Study: 20084307

Group type: EXPERIMENTAL
Intervention: Local anesthesia with 1.8mL of lidocaine 2% with epinephrine 1:100,000
Number of subjects: 31

Group type: COMPARATOR
Intervention: Local anesthesia with 1.8mL of lidocaine 2% without epinephrine
Number of subjects: 31
Study: 16906625

Group type: EXPERIMENTAL
Intervention: Consultation audiotape
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Standardized audiotape
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Both audiotapes
Number of subjects: 69
Study: 15118481

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Reboxetine
Number of subjects: 28
Study: 11915783

Group type: EXPERIMENTAL
Intervention: HIGH carbohydrate diet (greater than 70% of daily energy intake from CHO)
Number of subjects: 12

Group type: COMPARATOR
Intervention: LOW carbohydrate diet (less than 10% of daily energy intake from CHO)
Number of subjects: 12
Study: 9567151

Group type: EXPERIMENTAL
Intervention: (S)-ketamine/physostigmine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: (S)-ketamine/NaCl
Number of subjects: 12

Group type: COMPARATOR
Intervention: racemic ketamine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: (S)-ketamine
Number of subjects: 12
Study: 8045133

Group type: EXPERIMENTAL
Intervention: Cyclofem
Number of subjects: 1091

Group type: EXPERIMENTAL
Intervention: Mesigyna
Number of subjects: 1091

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 1091
Study: 2577393

Group type: EXPERIMENTAL
Intervention: Clindamycin (q.i.d. 300 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Cephradine (q.i.d. 250 mg)
Number of subjects: 8
Study: 31253489

Group type: EXPERIMENTAL
Intervention: ExT1D (online educational exercise tool)
Number of subjects: 32
Study: 27636247

Group type: EXPERIMENTAL
Intervention: 120 kVp/NI, 60
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 100 kVp/NI, 65
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 80 kVp/NI, 70
Number of subjects: 36

Group type: COMPARATOR
Intervention: 120 kVp/NI, 20 (control)
Number of subjects: 36
Study: 25264154

Group type: EXPERIMENTAL
Intervention: INSURE (intubate‐surfactant‐extubate)
Number of subjects: 60

Group type: COMPARATOR
Intervention: NCPAP alone
Number of subjects: 60
Study: 22372918

Group type: EXPERIMENTAL
Intervention: Nurse-CHW home visitation
Number of subjects: 530

Group type: COMPARATOR
Intervention: Standard community care (CC) including nurse home visitation
Number of subjects: 530
Study: 21825006

Group type: EXPERIMENTAL
Intervention: Olaparib in combination with fractionated radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olaparib alone or in combination with fractionated radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olaparib
Number of subjects: 0
Study: 19546759

Group type: EXPERIMENTAL
Intervention: Bovine pericardium graft
Number of subjects: 94

Group type: COMPARATOR
Intervention: Anterior colporrhaphy alone
Number of subjects: 94
Study: 16442874

Group type: EXPERIMENTAL
Intervention: Nutrition information program targeting protein consumption
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (no information provided)
Number of subjects: 82
Study: 15544709

Group type: EXPERIMENTAL
Intervention: Topical vapocoolant Fluori‐Methane (FM)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Cold saline placebo
Number of subjects: 185
Study: 11764063

Group type: EXPERIMENTAL
Intervention: Interapy treatment (experimental condition)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Waiting-list control condition
Number of subjects: 25
Study: 9338731

Group type: EXPERIMENTAL
Intervention: Terazosin (alpha1-adrenergic antagonist)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study: 8239013

Group type: EXPERIMENTAL
Intervention: Propofol infusion at 50 micrograms.kg‐1.min‐1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Propofol infusion at 75 micrograms.kg‐1.min‐1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Propofol infusion at 100 micrograms.kg‐1.min‐1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Initial bolus of propofol (2 mg.kg‐1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Propofol infusion (all doses)
Number of subjects: 30
Study: 3300953

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Chemotherapy (six cycles of vincristine, doxorubicin, and cyclophosphamide)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combination of radiotherapy and chemotherapy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Levamisole immunotherapy (150 mg/day, on 2 consecutive days weekly)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no levamisole)
Number of subjects: 120
Study: 28811076

Group type: EXPERIMENTAL
Intervention: 8mg dexamethasone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 40mg methylprednisolone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline injection (control)
Number of subjects: 60
Study: 26120010

Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg once daily)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol/norgestimate (0.035/0.25 mg once daily)
Number of subjects: 64
Study: 24833247

Group type: EXPERIMENTAL
Intervention: Venous Window Needle Guide (VWING)
Number of subjects: 54
Study: 23106930

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 131

Group type: COMPARATOR
Intervention: Both methadone and buprenorphine
Number of subjects: 131
Study: 20106825

Group type: EXPERIMENTAL
Intervention: Low-dose cyclosporine (CsA)
Number of subjects: 1645

Group type: EXPERIMENTAL
Intervention: Low-dose tacrolimus (Tac)
Number of subjects: 1645

Group type: EXPERIMENTAL
Intervention: Low-dose sirolimus (SRL)
Number of subjects: 1645

Group type: COMPARATOR
Intervention: Standard-dose cyclosporine (CsA)
Number of subjects: 1645

Group type: COMPARATOR
Intervention: Standard-dose cyclosporine without induction
Number of subjects: 1645
Study: 17651705

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 39

Group type: COMPARATOR
Intervention: High-dose olanzapine (up to 30 mg/day)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Clozapine and High-dose olanzapine
Number of subjects: 39
Study: 15653968

Group type: EXPERIMENTAL
Intervention: High-flow transtracheal insufflation of oxygen-enriched air at 15 L/min (fraction of inspired oxygen, 0.37)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Low-flow transtracheal insufflation of oxygen at 1.5 L/min
Number of subjects: 14
Study: 12437797

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Non-directive supportive counselling (SC)
Number of subjects: 32
Study: 10841003

Group type: EXPERIMENTAL
Intervention: Prediction rule based on sulfonylurea Rx, insulin Rx, duration of diabetes, and fasting glucose levels
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: Prediction rule
Number of subjects: 557
Study: 9347199

Group type: EXPERIMENTAL
Intervention: Ethanol infusion alone
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Ethanol with propranolol
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Ethanol with phentolamine
Number of subjects: 19

Group type: COMPARATOR
Intervention: Saline infusion alone
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Ethanol infusion
Number of subjects: 19
Study: 8227867

Group type: EXPERIMENTAL
Intervention: Hollister‐Stier lancet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ALK Laboratories lancet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bifurcated needle prick
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bifurcated needle puncture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multi‐Test device
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DermaPIK device
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline control sites
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall observation
Number of subjects: 0
Study: 3528436

Group type: EXPERIMENTAL
Intervention: Sputum cytological screening every 4 months combined with chest roentgenography (yearly or every 4 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chest roentgenography
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both sputum cytology and chest roentgenography every 4 months
Number of subjects: 0
Study: 29851090

Group type: EXPERIMENTAL
Intervention: Low level laser therapy (LLLT) in addition to conventional therapy (compression garments, massage therapy, exercise) for 6 weeks; treatment details: wavelength 980/810 nm (80:20 ratio), output power 500 mW, beam spot size 5 cm2, irradiance 100 mW/cm2, treatment time per area 1 minute, total dosage delivered 300 J.
Number of subjects: 17

Group type: COMPARATOR
Intervention: Conventional therapy alone (compression garments, massage therapy, exercise).
Number of subjects: 17
Study: 27404064

Group type: EXPERIMENTAL
Intervention: incentaHEALTH (INCENT; incentivized individually targeted Internet‐based intervention)
Number of subjects: 1460

Group type: COMPARATOR
Intervention: Livin' My Weigh (LMW; less‐intense quarterly newsletters)
Number of subjects: 1460
Study: 24236667

Group type: EXPERIMENTAL
Intervention: Unilateral pedicle screw fixation through a tubular retractor via the Wiltse approach
Number of subjects: 39

Group type: COMPARATOR
Intervention: Bilateral pedicle screw fixation via the posterior midline approach
Number of subjects: 39
Study: 22395260

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg midazolam
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg midazolam
Number of subjects: 60
Study: 20863007

Group type: EXPERIMENTAL
Intervention: Test FDC (rabeprazole 20 mg and diclofenac sodium 100 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference FDC (rabeprazole 20 mg and diclofenac sodium 100 mg)
Number of subjects: 0
Study: 18446720

Group type: EXPERIMENTAL
Intervention: Indoor activity
Number of subjects: 811

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 811

Group type: EXPERIMENTAL
Intervention: Outdoor activity
Number of subjects: 811
Study: 15745762

Group type: EXPERIMENTAL
Intervention: Brimonidine tartrate 0.2% (twice daily)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Timolol maleate 0.5% (twice daily)
Number of subjects: 190
Study: 12502976

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 30
Study: 11054909

Group type: EXPERIMENTAL
Intervention: Aspirin and thienopyridines (specific dosages and duration not mentioned)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Newer and more potent antiplatelet agents (specific agents not mentioned)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimization of antiplatelet therapy with aspirin and thienopyridines
Number of subjects: 0
Study: 8842505

Group type: EXPERIMENTAL
Intervention: Nanterinone 2 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 31718358

Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 63

Group type: COMPARATOR
Intervention: Aflibercept
Number of subjects: 63
Study: 30497837

Group type: EXPERIMENTAL
Intervention: 6 µg hemagglutinin per strain (FluArt, Hungary)
Number of subjects: 1206

Group type: COMPARATOR
Intervention: 15 µg hemagglutinin per strain (currently licensed vaccine)
Number of subjects: 1206
Study: 29270682

Group type: EXPERIMENTAL
Intervention: Running locked suture technique
Number of subjects: 28

Group type: COMPARATOR
Intervention: Interrupted suture technique
Number of subjects: 28
Study: 26747037

Group type: EXPERIMENTAL
Intervention: Daily smoking
Number of subjects: 11140

Group type: EXPERIMENTAL
Intervention: Quitting smoking
Number of subjects: 11140

Group type: COMPARATOR
Intervention: Never smoking
Number of subjects: 11140

Group type: EXPERIMENTAL
Intervention: Major coronary events
Number of subjects: 11140
Study: 24277680

Group type: EXPERIMENTAL
Intervention: Insulin degludec (0.4 U/kg, single subcutaneous dose)
Number of subjects: 24
Study: 23128937

Group type: EXPERIMENTAL
Intervention: Kinesitherapy (KT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Electrical Stimulation (ES)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Kinesitherapy combined with Electrical Stimulation (KT+ES)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: All rehabilitation programs
Number of subjects: 40
Study: 18816950

Group type: EXPERIMENTAL
Intervention: PETTLEP imagery
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Physical practice
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: PETTLEP + physical practice
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control
Number of subjects: 32